Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f873c586b280f965dd3090b8370d629 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a3377a5f0a21bf14208238f4db5ac5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29155e5ce29a65917e0de3d576ddfd4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7f30ffaaeeefbb38a8ac776855ad753 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059bb030770036876bbc4a94c68a71dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5537c7ba9fffbda37c59ee9272db01f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7725d277b07333c29be5f38f92695520 |
publicationDate |
2013-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2868000-A1 |
titleOfInvention |
Pharmaceutical combination comprising a mek inhibitor compound and an a nti-igfir antibody for treating cancer |
abstract |
The present invention relates to a pharmaceutical combination comprising a MEK inhibitor compound 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)- amide or a pharmaceutically acceptable salt thereof and the IGF1R inhibitor ANTIBODY A, a pharmaceutical composition comprising such combination, methods for treating cancer comprising administration of a therapeutically effective amount of such combination to a subject in need thereof, and uses of such combination for the treatment of cancer. |
priorityDate |
2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |